Truist Financial
IGC icon

Truist Financial’s IGC Pharma IGC Stock Holding History

Truist Financial’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.9K Sell
36,667
-12,000
-25% -$3.32K ﹤0.01% 2893
2026
Q2 		$13.2K Buy
48,667
+12,000
+33% +$3.55K ﹤0.01% 2909
2026
Q1 		$9.6K Hold
36,667
– – ﹤0.01% 2786
2025
Q4 		$10.3K Hold
36,667
– – ﹤0.01% 2756
2025
Q3 		$15.3K Hold
36,667
– – ﹤0.01% 2703
2025
Q2 		$11.2K Hold
36,667
– – ﹤0.01% 2585
2025
Q1 		$10.4K Hold
36,667
– – ﹤0.01% 2533
2024
Q4 		$12.3K Hold
36,667
– – ﹤0.01% 2501
2024
Q3 		$15.7K Hold
36,667
– – ﹤0.01% 2477
2024
Q2 		$15.9K Hold
36,667
– – ﹤0.01% 2628
2024
Q1 		$14.7K Hold
36,667
– – ﹤0.01% 2603
2023
Q4 		$10.3K Hold
36,667
– – ﹤0.01% 2621
2023
Q3 		$13.2K Hold
36,667
– – ﹤0.01% 2568
2023
Q2 		$11.4K Hold
36,667
– – ﹤0.01% 2550
2023
Q1 		$12.4K Hold
36,667
– – ﹤0.01% 2553
2022
Q4 		$11.7K Hold
36,667
– – ﹤0.01% 2538
2022
Q3 		$16K Hold
36,667
– – ﹤0.01% 2489
2022
Q2 		$19K Hold
36,667
– – ﹤0.01% 2604
2022
Q1 		$35K Hold
36,667
– – ﹤0.01% 2640
2021
Q4 		$36K Sell
36,667
-4,926
-12% -$6.61K ﹤0.01% 2712
2021
Q3 		$61K Hold
41,593
– – ﹤0.01% 2659
2021
Q2 		$68K Hold
41,593
– – ﹤0.01% 2663
2021
Q1 		$75K Buy
41,593
+4,926
+13% +$8.95K ﹤0.01% 2585
2020
Q4 		$57K Hold
36,667
– – ﹤0.01% 2501
2020
Q3 		$38K Hold
36,667
– – ﹤0.01% 2401
2020
Q2 		$22K Hold
36,667
– – ﹤0.01% 2362
2020
Q1 		$18K Hold
36,667
– – ﹤0.01% 2333
2019
Q4 		$23K Buy
+36,667
New +$30K ﹤0.01% 2459

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
AdvisorShares Investments
AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $145M AUM 29.71% 1-Year Est. Return
Dearborn Partners
Dearborn Partners Chicago, Illinois $1.65B AUM 8.8% 1-Year Est. Return

Truist Financial's IGC Position: Q3 2026 in Review

Truist Financial reduced its IGC Pharma (IGC) stake by 25% in Q3 2026, selling an estimated $3.32K and leaving 36,667 shares worth $9.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2893.

Truist Financial first reported a position in IGC in Q4 2019 and has held it in 28 quarters since. The position peaked at $75K in Q1 2021. 24 funds tracked by Wall St. Rank hold IGC as of Q3 2026.

  • Truist Financial held 36,667 shares of IGC Pharma worth $9.9K as of Q3 2026.
  • Truist Financial sold 12,000 IGC Pharma shares in Q3 2026, an estimated $3.32K.
  • IGC Pharma made up ﹤0.01% of Truist Financial's portfolio in Q3 2026, its #2893 holding.
  • Truist Financial first reported a position in IGC Pharma in Q4 2019 and has held it in 28 quarters since.
  • Truist Financial's IGC Pharma position peaked at $75K in Q1 2021.
  • 24 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2026.

Based on Truist Financial's 13F filing for Q3 2026, filed 30 Oct 2026.